Pfizer Inc. (PFE) Q1 2021 Earnings Results

Pfizer Beats on EPS, Stock Up 0.3%

Pfizer's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. The stock reacted modestly, rising 0.3%, likely driven by investor confidence in the company's vaccine performance and future product pipeline. However, the lack of revenue data and guidance may leave some investors cautious about the company's overall outlook.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.93	N/A	+17.42%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed optimism about the company's current trajectory, particularly in vaccine sales. They emphasized their commitment to innovation and efficiency.

Management highlighted strong performance in their vaccine segment.

They noted ongoing research and development efforts for future products.

The company remains focused on maintaining operational efficiency.

Pfizer Beats on EPS, Stock Up 0.3%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Up 0.3%

Key numbers

Management commentary